These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 8841942)
1. Multiplicity of kappa opioid receptor binding in the rat cardiac sarcolemma. Zhang WM; Jin WQ; Wong TM J Mol Cell Cardiol; 1996 Jul; 28(7):1547-54. PubMed ID: 8841942 [TBL] [Abstract][Full Text] [Related]
2. Characterization of opioid binding sites in rat spinal cord. Petrillo P; Kowalski J; Sbacchi M; Tavani A J Recept Res; 1992; 12(1):39-57. PubMed ID: 1314311 [TBL] [Abstract][Full Text] [Related]
3. Further characterization of [3H]U69593 binding sites in the rat heart. Jin WQ; Tai KK; Chan TK; Wong TM J Mol Cell Cardiol; 1995 Aug; 27(8):1507-11. PubMed ID: 8523414 [TBL] [Abstract][Full Text] [Related]
4. Kappa opioid binding sites in the dog cerebral cortex and spinal cord. Hunter JC; Birchmore B; Woodruff R; Hughes J Neuroscience; 1989; 31(3):735-43. PubMed ID: 2556660 [TBL] [Abstract][Full Text] [Related]
5. Opioid receptor ligands in the neonatal rat spinal cord: binding and in vitro depression of the nociceptive responses. James IF; Bettaney J; Perkins MN; Ketchum SB; Dray A Br J Pharmacol; 1990 Mar; 99(3):503-8. PubMed ID: 2158845 [TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of multiple kappa-opioid receptors by selective and nonselective ligand binding in guinea pig spinal cord: resolution of high and low affinity states of the kappa 2 receptors by a computerized model-fitting technique. Tiberi M; Magnan J Mol Pharmacol; 1990 May; 37(5):694-703. PubMed ID: 2160061 [TBL] [Abstract][Full Text] [Related]
7. Characterization of kappa opioid binding using dynorphin A1-13 and U69,593 in the rat brain. Devlin T; Shoemaker WJ J Pharmacol Exp Ther; 1990 May; 253(2):749-59. PubMed ID: 1971019 [TBL] [Abstract][Full Text] [Related]
8. Pharmacological characterization of the binding of [3H]bremazocine in guinea-pig brain: evidence for multiplicity of the kappa-opioid receptors. Tiberi M; Magnan J Can J Physiol Pharmacol; 1989 Oct; 67(10):1336-44. PubMed ID: 2558788 [TBL] [Abstract][Full Text] [Related]
9. A kinetic analysis of kappa-opioid agonist binding using the selective radioligand [3H]U69593. Smith JA; Hunter JC; Hill RG; Hughes J J Neurochem; 1989 Jul; 53(1):27-36. PubMed ID: 2723659 [TBL] [Abstract][Full Text] [Related]
10. Opioid binding sites in the guinea pig and rat kidney: radioligand homogenate binding and autoradiography. Dissanayake VU; Hughes J; Hunter JC Mol Pharmacol; 1991 Jul; 40(1):93-100. PubMed ID: 1649966 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological profile of various kappa-agonists at kappa-, mu- and delta-opioid receptors mediating presynaptic inhibition of neurotransmitter release in the rat brain. Mulder AH; Burger DM; Wardeh G; Hogenboom F; Frankhuyzen AL Br J Pharmacol; 1991 Feb; 102(2):518-22. PubMed ID: 1673074 [TBL] [Abstract][Full Text] [Related]
12. Opioid receptors in rat cardiac sarcolemma: effect of phenylephrine and isoproterenol. Ventura C; Bastagli L; Bernardi P; Caldarera CM; Guarnieri C Biochim Biophys Acta; 1989 Dec; 987(1):69-74. PubMed ID: 2557082 [TBL] [Abstract][Full Text] [Related]
13. Effects of U50488 and bremazocine on [Ca2+]i and cAMP in naive and tolerant rat ventricular myocytes: evidence of kappa opioid receptor multiplicity in the heart. Zhang WM; Wu S; Yu XC; Wang HX; Bian JS; Wong TM J Mol Cell Cardiol; 1999 Feb; 31(2):355-62. PubMed ID: 10093048 [TBL] [Abstract][Full Text] [Related]
14. Kappa1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum. Schoffelmeer AN; Hogenboom F; Mulder AH Br J Pharmacol; 1997 Oct; 122(3):520-4. PubMed ID: 9351509 [TBL] [Abstract][Full Text] [Related]
15. Demonstration of the heterogeneity of the kappa-opioid receptors in guinea-pig cerebellum using selective and nonselective drugs. Tiberi M; Magnan J Eur J Pharmacol; 1990 Jun; 188(6):379-89. PubMed ID: 2164939 [TBL] [Abstract][Full Text] [Related]
16. Pharmacological and anatomical evidence of selective mu, delta, and kappa opioid receptor binding in rat brain. Mansour A; Lewis ME; Khachaturian H; Akil H; Watson SJ Brain Res; 1986 Dec; 399(1):69-79. PubMed ID: 3026574 [TBL] [Abstract][Full Text] [Related]
17. Interaction of endogenous opioid peptides and other drugs with four kappa opioid binding sites in guinea pig brain. Rothman RB; Bykov V; de Costa BR; Jacobson AE; Rice KC; Brady LS Peptides; 1990; 11(2):311-31. PubMed ID: 2162533 [TBL] [Abstract][Full Text] [Related]
18. Probes for narcotic receptor mediated phenomena. 17. Synthesis and evaluation of a series of trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzeneacet amide (U50,488) related isothiocyanate derivatives as opioid receptor affinity ligands. de Costa BR; Rothman RB; Bykov V; Band L; Pert A; Jacobson AE; Rice KC J Med Chem; 1990 Apr; 33(4):1171-6. PubMed ID: 2157008 [TBL] [Abstract][Full Text] [Related]
19. Characterization of kappa-opioid receptors in the guinea-pig ileum. Dissanayake VU; Hunter JC; Hill RG; Hughes J Eur J Pharmacol; 1990 Jun; 182(1):73-82. PubMed ID: 2169427 [TBL] [Abstract][Full Text] [Related]
20. [3H]U-69593 labels a subtype of kappa opiate receptor with characteristics different from that labeled by [3H]ethylketocyclazocine. Nock B; Rajpara A; O'Connor LH; Cicero TJ Life Sci; 1988; 42(23):2403-12. PubMed ID: 2836684 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]